Literature for peptidase M12.209: ADAM9 peptidase

(Topics flags: A Assay, M Mutation, T Target, R Splicing, I Inhibitor, K Knockout, E Expression, V Review. To select only the references relevant to a single topic, click the link above. See explanation.)

2024
1. AmeliMojarad,M., AmeliMojarad,M., Wang,J., Tavakolpour,V. and Shariati,P.
   A pan-cancer study of ADAM9's immunological function and prognostic value particularly in liver cancer
   Sci Rep14, 26862-26862. PubMed  Europe PubMed DOI
2. Bazzone,L.E., Zhu,J., King,M., Liu,G., Guo,Z., Mackay,C.R., Kyawe,P.P., Qaisar,N., Rojas-Quintero,J., Owen,C.A., Brass,A.L., McDougall,W., Baer,C.E., Cashman,T., Trivedi,C.M., Gack,M.U., Finberg,R.W. and Kurt-Jones,E.A.
   ADAM9 promotes type I interferon-mediated innate immunity during encephalomyocarditis virus infection
   Nat Commun15, 4153-4153. PubMed  Europe PubMed DOI
3. Huang,Y.K., Cheng,W.C., Kuo,T.T., Yang,J.C., Wu,Y.C., Wu,H.H., Lo,C.C., Hsieh,C.Y., Wong,S.C., Lu,C.H., Wu,W.L., Liu,S.J., Li,Y.C., Lin,C.C., Shen,C.N., Hung,M.C., Lin,J.T., Yeh,C.C. and Sher,Y.P.
   Inhibition of ADAM9 promotes the selective degradation of KRAS and sensitizes pancreatic cancers to chemotherapy
   Nat Cancer5, 400-419. PubMed  Europe PubMed DOI
4. Jotatsu,Y., Sung,S.Y., Wu,M.H., Takeda,S., Hirata,Y., Maeda,K., Fang,S.B., Chen,K.C. and Shigemura,K.
   An Antibody of the Secreted Isoform of Disintegrin and Metalloprotease 9 (sADAM9) Inhibits Epithelial-Mesenchymal Transition and Migration of Prostate Cancer Cell Lines
   Int J Mol Sci25, PubMed  Europe PubMed DOI  K
5. Liu,J., Wang,Y., Zhang,S., Sun,L. and Shi,Y.
   ADAM9 deubiquitination induced by USP22 suppresses proliferation, migration, invasion, and epithelial-mesenchymal transition of trophoblast cells in preeclampsia
   Placenta146, 50-57. PubMed  Europe PubMed DOI
2022
6. Chandrasekera,P., Perfetto,M., Lu,C., Zhuo,M., Bahudhanapati,H., Li,J., Chen,W.C., Kulkarni,P., Christian,L., Liu,J., Yien,Y.Y., Yu,C. and Wei,S.
   Metalloprotease ADAM9 cleaves ephrin-B ligands and differentially regulates Wnt and mTOR signaling downstream of Akt kinase in colorectal cancer cells
   J Biol Chem298, 102225-102225. PubMed  Europe PubMed DOI  K
7. Liu,Z.H., Liu,W.J., Yu,X.Y., Qi,X.L. and Sun,C.C.
   Circ_0005276 aggravates the development of epithelial ovarian cancer by targeting ADAM9
   Eur Rev Med Pharmacol Sci26, 3798-3798. PubMed  Europe PubMed DOI
8. Xiao,Y., Ma,W., Hu,W., Di,Q., Zhao,X., Ma,X., Chen,X., Sun,P., Wu,H., Wu,Z. and Chen,W.
   Ubiquitin-specific peptidase 39 promotes human glioma cells migration and invasion by facilitating ADAM9 mRNA maturation
   Mol Oncol16, 388-404. PubMed  Europe PubMed DOI
2021
9. Umeda,M., Yoshida,N., Hisada,R., Burbano,C., Orite,S.Y.K., Kono,M., Kyttaris,V.C., Krishfield,S., Owen,C.A. and Tsokos,G.C.
   ADAM9 enhances Th17 cell differentiation and autoimmunity by activating TGF-beta1
   Proc Natl Acad Sci U S A118, PubMed  Europe PubMed DOI
2020
10. 
    Retraction: miR-126a-3p induces proliferation, migration and invasion of trophoblast cells in preeclampsia-like rats through inhibiting a disintegrin and metalloprotease 9(ADAM9)
    Biosci Rep40, PubMed  Europe PubMed DOI
11. Abety,A.N., Pach,E., Giebeler,N., Fromme,J.E., Aramadhaka,L.R., Mauch,C., Fox,J.W. and Zigrino,P.
    Loss of ADAM9 Leads to Modifications of the Extracellular Matrix Modulating Tumor Growth
    Biomolecules10, PubMed  Europe PubMed DOI
12. Lin,Y.W., Wen,Y.C., Chu,C.Y., Tung,M.C., Yang,Y.C., Hua,K.T., Pan,K.F., Hsiao,M., Lee,W.J. and Chien,M.H.
    Stabilization of ADAM9 by N-alpha-acetyltransferase 10 protein contributes to promoting progression of androgen-independent prostate cancer
    Cell Death Dis11, 591-591. PubMed  Europe PubMed DOI
13. Lu,W., Fei,A., Jiang,Y., Chen,L. and Wang,Y.
    Tetraspanin CD9 interacts with alpha-secretase to enhance its oncogenic function in pancreatic cancer
    Am J Transl Res12, 5525-5537. PubMed  Europe PubMed  K
2019
14. Baggen,J., Thibaut,H.J., Hurdiss,D.L., Wahedi,M., Marceau,C.D., van Vliet,A.L.W., Carette,J.E. and van Kuppeveld,F.J.M.
    Identification of the cell-surface protease ADAM9 as an entry factor for encephalomyocarditis virus
    MBio10, PubMed  Europe PubMed DOI  K
15. Wichert,R., Scharfenberg,F., Colmorgen,C., Koudelka,T., Schwarz,J., Wetzel,S., Potempa,B., Potempa,J., Bartsch,J.W., Sagi,I., Tholey,A., Saftig,P., Rose-John,S. and Becker-Pauly,C.
    Meprin beta induces activities of a disintegrin and metalloproteinases 9, 10, and 17 by specific prodomain cleavage
    FASEB J33, 11925-11940. PubMed  Europe PubMed DOI
2018
16. Wang,X., Polverino,F., Rojas-Quintero,J., Zhang,D., Sanchez,J., Yambayev,I., Lindqvist,E., Virtala,R., Djukanovic,R., Davies,D.E., Wilson,S., O'Donnell,R., Cunoosamy,D., Hazon,P., Higham,A., Singh,D., Olsson,H. and Owen,C.A.
    A disintegrin and a metalloproteinase-9 (ADAM9): a novel proteinase culprit with multifarious contributions to COPD
    Am J Respir Crit Care Med198, 1500-1518. PubMed  Europe PubMed DOI
2017
17. Maretzky,T., Swendeman,S., Mogollon,E., Weskamp,G., Sahin,U., Reiss,K. and Blobel,C.P.
    Characterization of the catalytic properties of the membrane-anchored metalloproteinase ADAM9 in cell-based assays
    Biochem J474, 1467-1479. PubMed  Europe PubMed DOI  I
2016
18. Moss,M.L., Minond,D., Yoneyama,T., Hansen,H.P., Vujanovic,N. and Rasmussen,F.H.
    An improved fluorescent substrate for assaying soluble and membrane-associated ADAM family member activities
    Anal Biochem507, 13-17. PubMed  Europe PubMed DOI  A
2015
19. Bahudhanapati,H., Bhattacharya,S. and Wei,S.
    Evolution of vertebrate ADAM genes; duplication of testicular ADAMs from ancient ADAM9/9-like loci
    PLoS ONE10, e0136281-e0136281. PubMed  Europe PubMed DOI
20. Chang,L., Gong,F. and Cui,Y.
    RNAi-mediated A disintegrin and metalloproteinase 9 gene silencing inhibits the tumor growth of non-small lung cancer in vitro and in vivo
    Mol Med Rep12, 1197-1204. PubMed  Europe PubMed DOI  K
21. Wong,E., Maretzky,T., Peleg,Y., Blobel,C.P. and Sagi,I.
    The functional maturation of A Disintegrin and Metalloproteinase (ADAM) 9, 10, and 17 requires processing at a newly identified proprotein convertase (PC) cleavage site
    J Biol Chem290, 12135-12146. PubMed  Europe PubMed DOI
2014
22. Kim,J.M., Jeung,H.C., Rha,S.Y., Yu,E.J., Kim,T.S., Shin,Y.K., Zhang,X., Park,K.H., Park,S.W., Chung,H.C. and Powis,G.
    The effect of disintegrin-metalloproteinase ADAM9 in gastric cancer progression
    Mol Cancer Ther13, 3074-3085. PubMed  Europe PubMed DOI  T
2012
23. Chan,K.M., Wong,H.L., Jin,G., Liu,B., Cao,R., Cao,Y., Lehti,K., Tryggvason,K. and Zhou,Z.
    MT1-MMP inactivates ADAM9 to regulate FGFR2 signaling and calvarial osteogenesis
    Dev Cell22, 1176-1190. PubMed  Europe PubMed DOI
24. Zigrino,P. and Mauch,C.
    ADAM9
    [ISSN:978-0-12-407744-7]3, 1101-1107. DOI
2011
25. Mongaret,C., Alexandre,J., Thomas-Schoemann,A., Bermudez,E., Chereau,C., Nicco,C., Goldwasser,F., Weill,B., Batteux,F. and Lemare,F.
    Tumor invasion induced by oxidative stress is dependent on membrane ADAM 9 protein and its secreted form
    Int J Cancer129, 791-798. PubMed  Europe PubMed DOI
26. Moss,M.L., Powell,G., Miller,M.A., Edwards,L., Qi,B., Sang,Q.X., De Strooper,B., Tesseur,I., Lichtenthaler,S.F., Taverna,M., Zhong,J.L., Dingwall,C., Ferdous,T., Schlomann,U., Zhou,P., Griffith,L.G., Lauffenburger,D.A., Petrovich,R. and Bartsch,J.W.
    ADAM9 inhibition increases membrane activity of ADAM10 and controls alpha-secretase processing of amyloid precursor protein
    J Biol Chem286, 40443-40451. PubMed  Europe PubMed DOI
27. Zigrino,P., Nischt,R. and Mauch,C.
    The disintegrin-like and cysteine-rich domains of ADAM-9 mediate interactions between melanoma cells and fibroblasts
    J Biol Chem286, 6801-6807. PubMed  Europe PubMed DOI
2010
28. Fry,J.L. and Toker,A.
    Secreted and membrane-bound isoforms of protease ADAM9 have opposing effects on breast cancer cell migration
    Cancer Res70, 8187-8198. PubMed  Europe PubMed DOI  R
29. Kohga,K., Takehara,T., Tatsumi,T., Ishida,H., Miyagi,T., Hosui,A. and Hayashi,N.
    Sorafenib inhibits the shedding of major histocompatibility complex class I-related chain A on hepatocellular carcinoma cells by down-regulating a disintegrin and metalloproteinase 9
    Hepatology51, 1264-1273. PubMed  Europe PubMed DOI
30. Mauch,C., Zamek,J., Abety,A.N., Grimberg,G., Fox,J.W. and Zigrino,P.
    Accelerated wound repair in ADAM-9 knockout animals
    J Invest Dermatol130, 2120-2130. PubMed  Europe PubMed DOI  K
31. Moss,M.L., Rasmussen,F.H., Nudelman,R., Dempsey,P.J. and Williams,J.
    Fluorescent substrates useful as high-throughput screening tools for ADAM9
    Comb Chem High Throughput Screen13, 358-365. PubMed  Europe PubMed DOI  A
2009
32. Franzke,C.W., Bruckner-Tuderman,L. and Blobel,C.P.
    Shedding of collagen XVII/BP180 in skin depends on both ADAM10 and ADAM9
    J Biol Chem284, 23386-23396. PubMed  Europe PubMed DOI  I
33. Guaiquil,V., Swendeman,S., Yoshida,T., Chavala,S., Campochiaro,P.A. and Blobel,C.P.
    ADAM9 is involved in pathological retinal neovascularization
    Mol Cell Biol29, 2694-2703. PubMed  Europe PubMed DOI
34. Parry,D.A., Toomes,C., Bida,L., Danciger,M., Towns,K.V., McKibbin,M., Jacobson,S.G., Logan,C.V., Ali,M., Bond,J., Chance,R., Swendeman,S., Daniele,L.L., Springell,K., Adams,M., Johnson,C.A., Booth,A.P., Jafri,H., Rashid,Y., Banin,E., Strom,T.M., Farber,D.B., Sharon,D., Blobel,C.P., Pugh,E.N., Jr., Pierce,E.A. and Inglehearn,C.F.
    Loss of the metalloprotease ADAM9 leads to cone-rod dystrophy in humans and retinal degeneration in mice
    Am J Hum Genet84, 683-691. PubMed  Europe PubMed DOI  M
35. Peduto,L.
    ADAM9 as a potential target molecule in cancer
    Curr Pharm Des15, 2282-2287. PubMed  Europe PubMed DOI  T
2008
36. Deuss,M., Reiss,K. and Hartmann,D.
    Part-time alpha-secretases: the functional biology of ADAM 9, 10 and 17
    Curr Alzheimer Res5, 187-201. PubMed  Europe PubMed DOI  K  V
37. Postina,R.
    A closer look at alpha-secretase
    Curr Alzheimer Res5, 179-186. PubMed  Europe PubMed DOI
2005
38. [YEAR:15-1-2005]Mahimkar,R.M., Visaya,O., Pollock,A.S. and Lovett,D.H.
    The disintegrin domain of ADAM9: a ligand for multiple beta1 renal integrins
    Biochem J385, 461-468. PubMed  Europe PubMed DOI
39. [YEAR:1-6-2005]Mazzocca,A., Coppari,R., De Franco,R., Cho,J.Y., Libermann,T.A., Pinzani,M. and Toker,A.
    A secreted form of ADAM9 promotes carcinoma invasion through tumor-stromal interactions
    Cancer Res65, 4728-4738. PubMed  Europe PubMed DOI
40. Peduto,L., Reuter,V.E., Shaffer,D.R., Scher,H.I. and Blobel,C.P.
    Critical function for ADAM9 in mouse prostate cancer
    Cancer Res65, 9312-9319. PubMed  Europe PubMed DOI  T
2004
41. Blobel,C.P.
    ADAM9
    [ISSN:0-12-079610-4]2, 715-717.  V
42. [YEAR:8-3-2004]Grutzmann,R., Luttges,J., Sipos,B., Ammerpohl,O., Dobrowolski,F., Alldinger,I., Kersting,S., Ockert,D., Koch,R., Kalthoff,H., Schackert,H.K., Saeger,H.D., Kloppel,G. and Pilarsky,C.
    ADAM9 expression in pancreatic cancer is associated with tumour type and is a prognostic factor in ductal adenocarcinoma
    Br J Cancer90, 1053-1058. PubMed  Europe PubMed DOI
43. [YEAR:15-6-2004]Shintani,Y., Higashiyama,S., Ohta,M., Hirabayashi,H., Yamamoto,S., Yoshimasu,T., Matsuda,H. and Matsuura,N.
    Overexpression of ADAM9 in non-small cell lung cancer correlates with brain metastasis
    Cancer Res64, 4190-4196. PubMed  Europe PubMed DOI
44. Wolfsberg,T.G. and White,J.M.
    ADAM metalloproteinases
    [ISSN:0-12-079610-4]2, 709-714.  V
2003
45. [YEAR:31-1-2003]Asai,M., Hattori,C., Szabo,B., Sasagawa,N., Maruyama,K., Tanuma,S. and Ishiura,S.
    Putative function of ADAM9, ADAM10, and ADAM17 as APP alpha-secretase
    Biochem Biophys Res Commun301, 231-235. PubMed  Europe PubMed DOI
46. [YEAR:20-7-2003]O'Shea,C., McKie,N., Buggy,Y., Duggan,C., Hill,A.D., McDermott,E., O'Higgins,N. and Duffy,M.J.
    Expression of ADAM-9 mRNA and protein in human breast cancer
    Int J Cancer105, 754-761. PubMed  Europe PubMed DOI
2002
47. [YEAR:31-7-2002]Amour,A., Knight,C.G., English,W.R., Webster,A., Slocombe,P.M., Knauper,V., Docherty,A.J., Becherer,J.D., Blobel,C.P. and Murphy,G.
    The enzymatic activity of ADAM8 and ADAM9 is not regulated by TIMPs
    FEBS Lett524, 154-158. PubMed  Europe PubMed DOI
48. Hooper,N.M. and Turner,A.J.
    The search for alpha-secretase and its potential as a therapeutic approach to Alzheimer s disease
    Curr Med Chem9, 1107-1119. PubMed  Europe PubMed  I
49. [YEAR:3-5-2002]Hotoda,N., Koike,H., Sasagawa,N. and Ishiura,S.
    A secreted form of human ADAM9 has an alpha-secretase activity for APP
    Biochem Biophys Res Commun293, 800-805. PubMed  Europe PubMed DOI  R
50. [YEAR:24-12-2002]Mohan,S., Thompson,G.R., Amaar,Y.G., Hathaway,G., Tschesche,H. and Baylink,D.J.
    ADAM-9 is an insulin-like growth factor binding protein-5 protease produced and secreted by human osteoblasts
    Biochemistry41, 15394-15403. PubMed  Europe PubMed DOI
51. Weskamp,G., Cai,H., Brodie,T.A., Higashyama,S., Manova,K., Ludwig,T. and Blobel,C.P.
    Mice lacking the metalloprotease-disintegrin MDC9 (ADAM9) have no evident major abnormalities during development or adult life
    Mol Cell Biol22, 1537-1544. PubMed  Europe PubMed DOI  K
2001
52. [YEAR:1-11-2001]Namba,K., Nishio,M., Mori,K., Miyamoto,N., Tsurudome,M., Ito,M., Kawano,M., Uchida,A. and Ito,Y.
    Involvement of ADAM9 in multinucleated giant cell formation of blood monocytes
    Cell Immunol213, 104-113. PubMed  Europe PubMed DOI
53. Schwettmann,L. and Tschesche,H.
    Cloning and expression in Pichia pastoris of metalloprotease domain of ADAM 9 catalytically active against fibronectin
    Protein Expr Purif21, 65-70. PubMed  Europe PubMed DOI  E
54. [YEAR:19-1-2001]Zhou,M., Graham,R., Russell,G. and Croucher,P.I.
    MDC-9 (ADAM-9/meltrin gamma) functions as an adhesion molecule by binding the alpha(v)beta(5) integrin
    Biochem Biophys Res Commun280, 574-580. PubMed  Europe PubMed DOI
2000
55. Mahimkar,R.M., Baricos,W.H., Visaya,O., Pollock,A.S. and Lovett,D.H.
    Identification, cellular distribution and potential function of the metalloprotease-disintegrin MDC9 in the kidney
    J Am Soc Nephrol11, 595-603. PubMed  Europe PubMed
56. Nath,D., Slocombe,P.M., Webster,A., Stephens,P.E., Docherty,A.J. and Murphy,G.
    Meltrin gamma (ADAM-9) mediates cellular adhesion through alpha(6)beta(1)integrin, leading to a marked induction of fibroblast cell motility
    J Cell Sci113, 2319-2328. PubMed  Europe PubMed
1999
57. [YEAR:15-10-1999]Koike,H., Tomioka,S., Sorimachi,H., Saido,T.C., Maruyama,K., Okuyama,A., Fujisawa-Sehara,A., Ohno,S., Suzuki,K. and Ishiura,S.
    Membrane-anchored metalloprotease MDC9 has an alpha-secretase activity responsible for processing the amyloid precursor protein
    Biochem J343, 371-375. PubMed  Europe PubMed DOI
58. [YEAR:1-11-1999]Nelson,K.K., Schlondorff,J. and Blobel,C.P.
    Evidence for an interaction of the metalloprotease-disintegrin tumour necrosis factor alpha convertase (TACE) with mitotic arrest deficient 2 (MAD2), and of the metalloprotease-disintegrin MDC9 with a novel MAD2-related protein, MAD2beta
    Biochem J343, 673-680. PubMed  Europe PubMed DOI
59. [YEAR:5-2-1999]Roghani,M., Becherer,J.D., Moss,M.L., Atherton,R.E., Erdjument-Bromage,H., Arribas,J., Blackburn,R.K., Weskamp,G., Tempst,P. and Blobel,C.P.
    Metalloprotease-disintegrin MDC9: Intracellular maturation and catalytic activity
    J Biol Chem274, 3531-3540. PubMed  Europe PubMed DOI
1998
60. [YEAR:13-2-1998]Inoue,D., Reid,M., Lum,L., Kratzschmar,J., Weskamp,G., Myung,Y.M., Baron,R. and Blobel,C.P.
    Cloning and initial characterization of mouse meltrin beta and analysis of the expression of four metalloprotease-disintegrins in bone cells
    J Biol Chem273, 4180-4187. PubMed  Europe PubMed DOI
61. [YEAR:15-12-1998]Izumi,Y., Hirata,M., Hasuwa,H., Iwamoto,R., Umata,T., Miyado,K., Tamai,Y., Kurisaki,T., Sehara-Fujisawa,A., Ohno,S. and Mekada,E.
    A metalloprotease-disintegrin, MDC9/meltrin-gamma/ADAM9 and PKC delta are involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor
    EMBO J17, 7260-7272. PubMed  Europe PubMed DOI
62. Olson,G.E., Winfrey,V.P., Matrisian,P.E., NagDas,S.K. and Hoffman,L.H.
    Blastocyst-dependent upregulation of metalloproteinase/disintegrin MDC9 expression in rabbit endometrium
    Cell Tissue Res293, 489-498. PubMed  Europe PubMed DOI
1996
63. Weskamp,G., Kratzschmar,J., Reid,M.S. and Blobel,C.P.
    MDC9, a widely expressed cellular disintegrin containing cytoplasmic SH3 ligand domains
    J Cell Biol132, 717-726. PubMed  Europe PubMed DOI